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Abstract
Background: Ocular infection with Toxoplasma gondii is a major preventable cause of blindness, especially in young
people. The aim of the present study was to assess detection rate of T. gondii DNA in blood samples of clinically diagnosed of ocular toxoplasmosis using uracil DNA glycosylase-supplemented loop-mediated isothermal amplification
(UDG-LAMP) and real-time quantitative PCR (qPCR) based on REP-529 and B1.
Methods: One hundred and seventeen patients with clinically diagnosed ocular toxoplasmosis (OT) were participated in the study as well as 200 control patients. Peripheral blood samples were assessed using UDG-LAMP and
qPCR techniques targeting REP-529 and B1.
Results: Detection limits of qPCR using REP-529 and B1 were estimated as 0.1 and 1 fg of T. gondii genomic DNA,
respectively. The limits of detection for UDG-LAMP using REP-529 and B1 were 1 and 100 fg, respectively. In this study,
18 and 16 patients were positive in qPCR using REP-529 and B1, respectively. Based on the results of UDG-LAMP, 15
and 14 patients were positive using REP-529 and B1, respectively. Results of the study on patients with active ocular
lesion showed that sensitivity of REP-529 and BI targets included 64 and 63%, respectively using qPCR. Sensitivity of 62
and 61%, were concluded from UDG-LAMP using REP-529 and B1 in the blood cases of active ocular lesion. qPCR was
more sensitive than UDG-LAMP for the detection of Toxoplasma gondii DNA in peripheral blood samples of patients
with clinically diagnosed toxoplasmic chorioretinitis. Furthermore, the REP-529 included a better detection rate for the
diagnosis of ocular toxoplasmosis in blood samples, compared to that the B1 gene did. Moreover, the qPCR and UDGLAMP specificity assessments have demonstrated no amplifications of DNAs extracted from other microorganisms
based on REP-529 and B1.
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Conclusions: Data from the current study suggest that qPCR and UDG-LAMP based on the REP-529 are promising
diagnostic methods for the diagnosis of ocular toxoplasmosis in blood samples of patients with active chorioretinal
lesions.
Keywords: Toxoplasma gondii, Chorioretinitis, UDG-LAMP, Real-time PCR, Peripheral blood

Background
Ocular toxoplasmosis (OT), one of the major causes of
posterior uveitis globally, can lead to vision-threatening
complications such as retinal detachment, choroidal neovascularization and glaucoma. The disease is associated
with congenital or postnatally acquired infection caused
by the ubiquitous apicomplexan parasite Toxoplasma
gondii (T. gondii) and classically presents as a necrotizing retinochoroiditis that can be single [1], multiple [2]
or satellite [3] to atrophic-pigmented scars. Congenitally
infected people, who are asymptomatic at birth [4], may
later develop toxoplasmosis symptoms [5]. Diagnosis of
OT is routinely carried out through ophthalmic examinations and various clinical findings that confirm T. gondii
infection of the retinochoroiditis. However, the clinical
presentation can at times prove to be misleading [6, 7],
requiring further biological tests [8] to be either confirmed or refuted [9]. When definitive clinical diagnosis
cannot be carried out, a direct detection of T. gondii DNA
using conventional polymerase chain reaction (PCR) [10]
and antibody detection [11] with titer interpretation from
the blood and/or ocular samples are successfully used
to verify the primary diagnosis [12–14]. These methods
cannot only confirm the OT diagnosis but can also rule
out other similar infectious diseases [7, 15].
From various molecular techniques, real-time quantitative PCR (qPCR) and LAMP assays are particularly
popular because of their high sensitivity, specificity and
speed. The LAMP technique is carried out under isothermal reaction conditions and does not need advanced

equipment [16–19]. The major problem of using molecular methods for the ocular fluids is linked to the invasive
nature of these methods [14]. Significantly, peripheral
blood sampling is less invasive than ocular fluid sampling. In the current study, qPCR and UDG-LAMP assays
were assessed for the detection of T. gondii DNA in blood
samples of clinically diagnosed OT patients using repetitive REP-529 sequence and B1 gene.

Methods
Patients and clinical sample collections

This cross-sectional study was designed using 117 immunocompetent patients with clinically diagnosed OT in
Farabi Eye Hospital, Tehran, Iran, from October 2015
to August 2017. The OT was clinically diagnosed by a
retina specialist (MZ). Chorioretinal involvements of T.
gondii were classified into three major groups based on
fundoscopic examination, including (1) Group A (active
lesion): an area of white edematous retina with ill-defined
borders and overlying vitritis, usually accompanied by
nearby vasculitis (Fig. 1A). This appearance represents
the active form of disease and when seen with no scars
is considered as a consequence of the primary acquired
infection [20]; (2) Group B (old scar): a chorioretinal scar
with sharp borders and variable degrees of dark pigmentation (Fig. 1B). This appearance represents the inactive
form of disease and is considered as a reminiscence of
the active prior chorioretinitis [21, 22] and (3) Group C
(reactivated disease): a combination of the two forms,
including an area of active chorioretinitis in eyes with

Fig. 1 Clinical manifestation of ocular toxoplasmosis; A Toxoplasma retinitis (active disease), B Retinochoroiditis scar (old scar), C Toxoplasma
retinitis and adjacent retinochoroiditis scar (reactivated disease)
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toxoplasmic chorioretinal scars, usually close to an active
chorioretinitis focus (Fig. 1C). This form may be resulted
from the failure of immune system to continually limit
the infected foci and subsequent release of the tissue cyst
content into the close tissues [23]. Moreover, 200 patients
with other eye diseases other than toxoplasmosis, including viral keratitis (39 samples), amebic keratitis (38
samples), fungal keratitis (42 samples), bacterial endophthalmitis (64 samples) and cataract (17 samples) were
participated as controls. Blood samples (up to 3.5 mL)
were collected from the participants using EDTA-containing tubes. These blood samples have been verified
using various biological techniques by the authors in previous studies [24, 25].
DNA extraction

DNA was extracted from the whole blood using QIAamp
Genomic DNA Blood Mini Extraction Kit (Qiagen,
Hilden, Germany) based on the manufacturer instructions and kept frozen at − 20 °C for further use in qPCR
and UDG-LAMP reactions [25]. The reference DNA was
extracted from a virulent RH strain of T. gondii (Type I),
which was previously collected from peritoneal cavity of
the infected mice [26].
qPCR

A TaqMan-probe qPCR targeting REP-529 and B1
was developed using StepOne Real-Time PCR System
(Applied Biosystems, Foster City, CA, USA) with 45
cycles of amplification. REP-529 is a highly repetitive
sequence with 200–300 copies in T. gondii genome [27].
The B1 gene has 35 copies in the genome and is conserved indifferent parasite strains [28]. The PCR reaction
included RealQ Plus Master Mix for probes labeled with
reporter fluorophor 6-carboxyfluorescein (Ampliqon,
Odense, Denmark) (10 µL), TagMan probe (FAMCCCTCGC CCTCTTCTC CAC TCT TCA A-3-BHQ1)
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(0.2 µM), extracted DNA (5 µL), forward (5ʹ-CTTCGT
CCAAGCCTCCGA-3ʹ) and reverse (5ʹ-GACGCTTTC
CTCGTG GTGAT-3ʹ) primers (0.4 µL) and distilled
water (4 µL). The PCR thermal cycling was carried out
at 95 °C for 5 min and continued for 40 cycles of 95 °C
for 1 min, annealing at 55 °C for 1 min and extension at
72 °C for 1 min. The gapdh gene was used as housekeeping gene with primers common to all mammalian species to check the quality of DNA [18]. An internal control
(TaqMan exogenous positive control) was used, and each
run was considered valid if the positive, negative, and
internal controls were acceptable. The result was considered negative if repeated atypical amplification curves
with proper amplification of the internal control was
present. A sample was considered inhibited if amplification of the internal control failed and there was no amplification or atypical amplification curve for the target of
interest.
Uracil DNA glycosylase‑supplemented loop‑mediated
isothermal amplification assay

UDG-LAMP assay was successfully performed in our
laboratory as described previously [29]. Specific oligonucleotide primers for T. gondii used for the LAMP assay
were designed based on REP-529 and B1 regions of the
parasite genome (Table 1). The total reaction master mix
volume was 25 μL consisting of 1 μL of template DNA,
40 picomol of each of FIP and BIP primers, 20 pmol of
each LF and LB primers (used only in REP-LAMP),
5 pmol of each of F3 and B3 primers, 8 U of Bst2 DNA
polymerase (New England Biolabs, USA), 1.4 mmol/L of
deoxyuridine triphosphates (dUTP) instead of dTTP and
2X reaction buffer, containing 1.6 mol/L betaine (Sigma
Aldrich, USA), 40 mmol/L Tris–HCl (pH 8.8), 20 mmol/L
of KCL, 20 mmol/L of (NH4)2SO4, 16 mmol/L of MgSO4
and 0.2% tween 20). The LAMP assay were carried out at
60–67 °C for 30, 45, 60 and 75 min to find the optimum

Table 1 Nucleotide sequences of LAMP primers for molecular diagnosis of T. gondii
Genes

Primers

Size

Accession number

B1

BIP-5′-TCGCAACGGAGTTCTTCCCAGT TTTGGCCTGATATTACGACGGAC-3′

212 bp

AF179871

202 bp

AF146527

FIP-5′-TGACGCC TTTAGCACATCTGGT TTTTGATGCTCAAAGTCGACCGC-3′
F3-5′-GGGAGCAAGAGTTGGGACTA-3′
B3-5′CAGACAGCGAACAGAACAGA-3′
REP-529

BIP-5′-TGGT TGGGAAGCGACGAGAGTTCCAGGAAAAGCAGCCAAG-3′
FIP-5′-TCCTCACCCTCGCCTTCATCTAGGACTACAGACGCGATGC-3′
LF-5′-TCCAAGACGGCTGGAGGAG-3′
LB-5′-CGGAGAGGGAGAAGATGTT TCC-3′
F3-5′-CCACAGAAGGGACAGAAGTC-3′
B3-5′-TCCGGTGTCTCTT TTTCCAC-3′
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time and temperature conditions and finally; 63 °C and
60 min were the best temperature and time for both target genes, respectively. Addition of 3 µL of the fluorescent detection reagent, diluted SYBR Green I (Invitrogen,
Carlsbad, California, USA), to the reaction tube after
LAMP reaction enables visible analysis of the results
under daylight and/or UV light. The positive amplification was read through observation of change in color of
the reaction mixture following addition of dye to the tube
and the color changes from orange (negative reaction) to
green (positive reaction) (Fig. 2). The results were further
verified by electrophoresis of LAMP products in 1.5%
agarose gel electrophoresis stained with DNA Safe Stain
(SinaClon, Iran), and visualized under UV light. To prevent self-amplification of the primers, reactions were carried out in the absence of DNA templates. The T. gondii
RH-strain DNA and double distilled water were used as
positive and no template controls, respectively. To assess
reproducibility of the assay, all experiments were carried
out in duplicate. The protocol is fully described in a previous study by the authors [29, 30].
Analytical sensitivity and specificity of qPCR
and UDG‑LAMP assays

To assess analytical sensitivity of the qPCR and UDGLAMP techniques for the detection of T. gondii (RH
strain) DNA, tenfold serial dilutions of T. gondii DNA
with 1 pg to 0.01 fg concentrations were prepared and
used in qPCR and LAMP assays targeting REP-529 and
B1. The construction is performed with various concentrations of DNA. Next, the cycle threshold (CT) values
were plotted as mean (triplicate) against the standard
curve values to determine the detection limit of both
primer sets. Parasite concentrations are determined
after the calculation of the linear regression equation (y = ax + b), where y = CT; a = curve slope (slope);
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x = parasite number; and b = where the curve intersects
y-axis (y intercept) [31, 32].
To assess the analytical specificity of the qPCR and
UDG-LAMP techniques, extracted DNAs from other
microorganisms, including Leishmania tropica, L. major,
Giardia lamblia, Cryptosporidium parvum, Entamoeba
dispar, Trichostrongylus colubriformis, Corynosoma capsicum, Candida albicans and Acanthamoeba spp. as well
as human chromosomal DNA, were used as templates in
qPCR and LAMP assays using specific primers of REP529 and B1.
Statistical analysis

Data were analyzed using SPSS Software v.21 (SPSS Inc.
Chicago, IL, USA). The χ2 test was used to calculate diagnostic sensitivity and specificity of the qPCR and UDGLAMP techniques. Agreements between the clinical and
molecular assays were demonstrated using Cohen’s kappa
coefficient [33]. Linear regressions were constructed
from the standard curves for REP-529 and B1 and CT
mean comparison of both primer pairs. Both curves were
statistically analyzed using an unequal-variance t-test
based on a critical value of p ≤ 0.05.

Results
Distribution of participants

Of the total samples, 55.55% (65/117) belonged to males
and 44.44% (52/117) to females. Thirty six (30.76%)
patients were up to 10 years old, 50 (42.73%) patients were
11–20 years old, 23 (19.65%) patients were 21–30 years
old and eight (6.83%) patients were 31–40 years old. Of
117 patients, 37 (31.62%) patients included active lesions
(Group A), 13 (11.11%) patients included pigmented
scars (Group B) and 67 (57.26%) patients included pigmented scars with active lesions (Group C).

Fig. 2 Tubes with UDG-LAMP reaction stained with SYBR Green I. C+ , positive control; C-, negative control; 1–4, different patients with positive
reactions. The color changes from orange (negative reaction) to green (positive reaction)
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qPCR and UDG‑LAMP of the clinical samples

Out of 37 patients in Group A (patients with active
lesions), 18 and 16 patients were positive by qPCR using
REP-529 and B1 and 15 and 14 patients were positive
by UDG-LAMP using REP-529 and B1, respectively. All
positive results using UDG-LAMP had 100% overlaps
with positive results of qPCR using REP-529 and B1.
None of the patients in other clinical groups (Groups B
and C) were positive using molecular assays (Table 2). All
patients in control group were negative for REP-529 and
B1 using qPCR and UDG-LAMP. Amplification plot and
derivative melt curve analysis of the T. gondii based on
REP-529 and B1 targets are shown in Fig. 3. The results
of chi-square test indicated that qPCR method based on
REP-529 was the most sensitive than UDG-LAMP using
REP-529 and B1 (P = 0.003).
Analytical sensitivity of qPCR and UDG‑LAMP assays

The first step was to assess the reportable range of the
reaction that was determined utilizing T. gondii DNA
isolate from tachyzoites (RH strain) using the REP-529
(Fig. 4A) and B1 (Fig. 4B). The current results showed
that the detection limits for UDG-LAMP using REP-529
and B1 were 1 and 100 fg, respectively. Detection limits
of qPCR using REP-529 and B1 were estimated as 0.1 and
1 fg of T. gondii genomic DNA, respectively (Figs. 4, 5).
Specificity of qPCR and UDG‑LAMP assays

Using qPCR and UDG-LAMP, no amplifications were
detected in reactions with DNA of G. lamblia, C. parvum, E. dispar, L. major, Acanthamoeba spp., T. colubriformis, C. capsicum and C. albicans as well as human
genomic DNA (Fig. 6).
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Discussion
Although clinical examination is the standard method for
the diagnosis of OT in the second and third forms of the
disease (old scars and reactivated disease), the first form
of disease (active lesions) cannot always be differentiated from other chorioretinal inflammations based on
funduscopic appearance alone [34]. Based on the previous studies, ocular fluid samples are the most sensitive
sources for the molecular diagnosis of OT [15, 34, 35].
Molecular examination of the aqueous humor puncture
allows identification of coinfections or various etiological agents for the infectious uveitis. It is noteworthy that
coinfections need various treatments in addition to antiToxoplasma therapy [15]. However, the most important
limitation of this method is linked to its invasive nature
that may hurt the eyes [20, 36].
PCR of blood samples from patients with OT produced
similar results to those from PCR of aqueous humor samples, avoiding problems associated with ocular puncture
[37]. More recently, Khanaliha et al. have reported that
peripheral blood mononuclear cells (PBMCs) are appropriate for the assessment of toxoplasmic chorioretinitis.
Furthermore they have reported that PCR with bradyzoite genes is useful for the diagnosis of toxoplasmic chorioretinitis in these cells [38]. In a previous study by the
current authors, agreements between the two approaches
of nested PCR and serological assays were assessed and
results highlighted that nested-PCR of peripheral blood
samples was a useful minimally invasive technique for
providing direct evidence of the presence of T. gondii in
patients with OT, especially in recently acquired infections. Nested-PCR with REP-529 target included 57 and
100% sensitivity and specificity in diagnosis of recently

Table 2 Summary results of ocular toxoplasmosis using qPCR and LAMP techniques based on REP-529 sequence and B1 gene among
different clinically manifestations
Molecular and clinical results

Real-time PCR
REP-529

Group A (n = 37)

Kappa value

Group C (n = 67)

Kappa value

Group B (n = 13)

Kappa value

LAMP
B1

REP-529

B1

18 (48.64%)

16 (43.24%)

15 (40.54%)

14 (37.83%)

0.796

0.732

0.664

0.628

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0.558

0.584

0.611

0.639

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0.122

0.136

0.148

0.154

P- value

0.001

0.001

0.001

0.001

Sensitivity

64%

63%

62%

61%

Specificity

100%

100%

100%

100%

Positive predictive value (PPV)

100%

100%

100%

100%

Negative predictive value (NPV)

90%

90%

90%

89%

Group A, 37 cases of active lesion (Toxoplasma retinitis); Group B, 67 cases of old scar (Retinochoroiditis scar); Group C, 13 cases of reactivated disease (Toxoplasma
retinitis and adjacent retinochoroiditis scar)
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Fig. 3 qPCR amplification plot based on REP-529 and B1 targets of T. gondii from blood samples of patients suspected to ocular toxoplasmosis

Fig. 4 Standard curve of T. gondii, tachyzoites using REP-529 (A) and B1 (B) primer sets, respectively. Results are shown as mean cycle threshold (CT)
obtained from triplicate of each DNA concentration. Standard curve analysis was performed in tenfold serial dilutions of T. gondii DNA extracted
from tachyzoites, at initial concentration of 1000 fg/μL

acquired OT, respectively [25]. In contrast, studies have
revealed that molecular testing on peripheral blood samples is not sufficiently sensitive for the detection of T.

gondii in patients with OT [35]. In a study, Bourdin et al.
reported 35.9% sensitivity in diagnosis of OT using PCR
of peripheral blood samples. These studies showed that
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Fig. 5 Comparison of the sensitivity of the REP-529 bp (A) and B1
(B) genes using UDG-LAMP assay in diagnosis of T. gondii (RH strain)
DNA. N: negative control, P: positive control, M: 100 bp DNA Marker,
lanes 1–6: 1 pg, 100 fg, 10 fg, 1 fg, 0.1 fg and 0.01 fg of T. gondii (RH
strain) DNA

in OT it is possible to detect T. gondii DNA in peripheral
blood samples without a direct relation of Toxoplasma
activity within the eye. They concluded that PCR technique was not sensitive enough for the diagnosis of OT
from blood samples [39]. Several factors affect sensitivity
of molecular techniques, including volumes and types of
the samples, DNA markers, gene targets and types of the
molecular methods [34].
In the current study, we detected T. gondii DNA in the
blood of patients with active ocular lesions (Group A)
using qPCR and UDG-LAMP based on REP-529 and B1,
but not in the blood of patients with old scars (Group B)
and reactivated disease (Group C), which suggests that
parasitaemia is associated with ongoing disease. Tachyzoites of T. gondii have been isolated from the blood of
immunocompetent patients with the ocular disease but
not from the blood of patients with recurrent retinochoroiditis [40]. However, Silveira et al. have reported
that subclinical parasitaemia is present in patients with
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either acute or chronic toxoplasmosis, regardless of the
presence of ocular disease [41]. Although assays of this
study did not include high sensitivities in all OT patients,
these sensitivities were acceptably high in patients from
the Group A. The presence of an old pigmented scar is
usually the most useful and characteristic clinical finding in the diagnosis of OT. This clinical finding is absent
in patients with active lesions resulted from recently
acquired toxoplasmosis in contrast to patients with
active lesions resulted from reactivation of congenitally
acquired toxoplasmosis (Group C) [2, 22]. It is noteworthy that the Group B patients included old inactive scars
alone with no active chorioretinitis lesions and hence
did not need treatments and Group C patients included
pathognomonic clinical findings of simultaneous presence of old scars and active chorioretinitis lesions and
thus did not need confirmatory paraclinical diagnostic
assessments [21, 23].
In the current study, detection limits of qPCR using
REP-529 and B1 targets were respectively estimated
as 0.1 and 1 fg of the T. gondii genomic DNA. Detection limits of UDG-LAMP using the highlighted targets
were 1 and 100 fg of the T. gondii genomic DNA, respectively. Kong et al. reported detection limits of RE-LAMP,
B1-LAMP and RE-nested PCR assays as 0.6, 60 and
600 fg of the DNA templates, respectively [42]. A similar study by Zhang et al. revealed that the detection limits of LAMP and conventional PCR assays using REP-529
target were 1 and 10 pg, respectively [43]. Various target
genes such as SAG1, SAG2, SAG3, SAG4, ITS, B1, REP529, P30, GRA4, GRA6 and GRA7 have been used to
detect toxoplasmosis [44–48]. The results have shown
that both REP-529 and B1 are highly sensitive; REP-529
is more sensitive than B1 gene. [32, 49, 50]. Therefore,
the present technique was based on the REP-529 and B1.
Based on the results from a study by da Silva et al., it has
been shown that the REP-529 includes 200–300 copies
in the genome of Toxoplasma parasite, the highest copy
number within all studied genes that are quite specific to
T. gondii [51]. Furthermore, several studies have reported
that the B1 gene includes 35 copies in genome of T. gondii, which is completely specific [17, 52–54]. The SAG1,
SAG2, SAG3, SAG4, GRA4, GRA6 and GRA7 genes
include only one copy in genome of T. gondii, which are
specific as well [46]. Studies have shown that the number of copies of each gene fragment includes direct relationships with the diagnosis sensitivity [48, 52]. Another
factor that is important in selecting appropriate gene
fragments is specificity [55]. The current results have
shown no cross-reactivity with DNA corresponding to
parasitic infections other than toxoplasmosis using qPCR
and UDG-LAMP based on REP-529 and B1, thereby
insuring high specificity for target amplification [27, 56].
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Fig. 6 Analytical specificity of UDG-LAMP assay. P: positive control (T. gondii, RH strain), lanes 1–9: DNA of Giardia lamblia, Cryptosporidium parvum,
Entamoeba dispar, Leishmania major, Acanthamoeba, Trichostrongylus colubriformis, Corynosoma capsicum, Candida albicans and Human Genomic
DNA

Conclusion
Results of the current study have shown that samples
from peripheral blood samples can potentially be used
for the molecular diagnosis of OT in patients with active
chorioretinal lesions. In the present study, qPCR was
more sensitive than UDG-LAMP. However, UDG-LAMP
can be used in fields, potentially excluding needs of
expensive PCR machines and gel electrophoresis devices
as well as laborious DNA extraction processes. Regarding the gene target, RE was more sensitive than B1 gene.
Moreover, the qPCR and UDG-LAMP specificity assessments have demonstrated no amplifications of DNAs
extracted from other microorganisms based on REP-529
and B1. Therefore, data from the current study suggest
qPCR and UDG-LAMP of REP-529 as promising diagnostic techniques for the diagnosis of OT in blood samples of patients with active chorioretinal lesions.
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